ImmunityBio (IBRX) Net earnings per share growth forecast for next year
Expectations for ImmunityBio, Inc. (IBRX) EPS growth next year rely on the powerful technological foundation of the company's US laboratories. However, 69.10 becomes the new value for this metric amid high capital burn and FDA regulatory risks. The business is currently focusing on establishing a distribution network for its first drug, completely ruling out merger deals with other players.
Metric breakdowns and analytics for immunitybio.com (IBRX)
- price and consensus price forecast:
- market capitalization details:
- company book value details:
- company liabilities and liquidity data:
- earnings and market ratios statistics:
IBRX - Company Net Income|Expected Profit ImmunityBio, Inc.|IBRX - Company Value to Net Income|Forward P/E Multiple ImmunityBio, Inc.|IBRX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImmunityBio|IBRX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months ImmunityBio|IBRX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth immunitybio.com|IBRX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year ImmunityBio, Inc.
Analysis of all company metrics:ImmunityBio Corp
This indicator reflects the daily aggregation of expert expectations regarding net profit growth rates, allowing for a correlation between the current share price of ImmunityBio, Inc. (IBRX) and its future returns. By analyzing the consensus for next year's earnings per share (EPS) changes, investors can see the impact of the commercialization of the unique IL-15 therapy and patent protection, which confirms the fundamental resilience of the business in the face of competitors.
Direct competitors
Net earnings per share growth forecast for next year Immunocore PLC|Expected earnings per share growth for next year Janux Corp (JANX)|Net earnings per share growth forecast for next year Arcus Biosciences, Inc. (RCUS)|Expected earnings per share growth for next year zymeworks.com ZYME|Tango Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Iovance Biotherapeutics Inc IOVA|IMTX - Net earnings per share growth forecast for next year|XNCR (Xencor Inc.) - Projected earnings per share growth rate for next year|Compass Therapeutics (CMPX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year replimune.com (REPL)|Expected earnings per share growth for next year LYEL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech, Inc.)|Expected earnings per share trend next year STRO|MiNK Therapeutics - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics|immixbio.com (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings Inc. - Expected earnings per share trend next year|CUE (Cue Biopharma, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year PDS Biotechnology Corp|Net earnings per share growth forecast for next year Sonnet BioTherapeutics (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Corp - Expected earnings per share growth for next year|LAVA Therapeutics NV (LVTX) - Expected net earnings per share growth next year|NextCure, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Leap Therapeutics, Inc. LPTX|intensitytherapeutics.com (INTS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Sensei Biotherapeutics, Inc.|Net earnings per share growth forecast for next year Synthetic Biologics|Expected earnings per share growth for next year Gritstone Bio (GRTS)|Expected earnings per share growth for next year KA (Kineta, Inc.)|Earnings growth forecast for next year neximmune.com (NEXI)|Net earnings per share growth forecast for next year Turnstone Biologics Corp. TSBX|VCNX: Projected earnings per share growth rate for next year|Harpoon Tx - Earnings growth forecast for next year
